Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease

Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease

OBJECTIVES: This study assessed the protective effect of calcium dobesilate against contrast-induced nephropathy (CIN) after coronary angiography (CAG) or percutaneous coronary intervention (PCI) in patients with diabetes and chronic kidney disease (CKD). METHODS: A total of 130 patients with diabe...

Full description

Bibliographic Details
Main Authors:	Hao Zhang, Shao-Hua Guo, Zheng-Kai Xue, Ya-Ru Zhang, Jia-Rui Wang, Jing-Jin Che, Tong Liu, Hua-Yue Tao, Guang-Ping Li, Seung-Woon Rha, Swapnil-Zaman Ashraful-Haque, Kang-Yin Chen
Format:	Article
Language:	English
Published:	Elsevier España 2021-10-01
Series:	Clinics
Subjects:	Calcium dobesilate Contrast-Induced Acute Kidney Injury Diabetes Mellitus Chronic Renal Insufficiency Coronary Angiography
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100319&tlng=en

Similar Items

A STUDY ON TOPICAL CALCIUM DOBESILATE FOR THE TREATMENT OF LIMITED PLAQUE PSORIASIS
by: Neerja Puri, et al.
Published: (2013-07-01)

Calcium dobesilate ameliorates hepatorenal injury induced by carbon tetrachloride in mice
by: Elham Hakimizadeh, et al.
Published: (2022-02-01)

The Effect of Calcium Dobesilate on Liver Damage in Experimental Obstructive Jaundice
by: Yilmaz Unal, et al.
Published: (2019-04-01)

Efficacy of prophylactic calcium dobesilate in renal ischemia-reperfusion injury in rats
by: Ali Akkoç, et al.
Published: (2020-07-01)

Calcium Dobesilate Reverses Cognitive Deficits and Anxiety-Like Behaviors in the D-Galactose-Induced Aging Mouse Model through Modulation of Oxidative Stress
by: Elham Hakimizadeh, et al.
Published: (2021-04-01)

The effectiveness and safety of Chinese patent medicines plus calcium dobesilate for the treatment of diabetic retinopathy: A network meta-analysis
by: Xiyuan Deng, et al.
Published: (2024-02-01)

Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology
by: Bingyu Du, et al.
Published: (2022-09-01)

The effect of Ca-Dobesilate over renal scar formation in an experimental pyelonephritis model
by: Gülfiliz Gönlüşen, et al.
Published: (2020-12-01)

Effect of Adding Oral Calcium Dobesilate to Laser Photocoagulation on the Macular Thickness in Patients with Diabetic Macular Edema: A Randomized Clinical Trial
by: Mostafa Feghhi, et al.
Published: (2014-12-01)

Calcium Dobesilate Modulates PKCδ-NADPH Oxidase- MAPK-NF-κB Signaling Pathway to Reduce <i>CD14</i>, <i>TLR4</i>, and <i>MMP9</i> Expression during Monocyte-to-Macrophage Differentiation: Potential Therapeutic Implications for Atherosclerosis
by: Florence Njau, et al.
Published: (2021-11-01)

Editorial: Contrast-induced nephropathy
by: Sinan Aydoğdu
Published: (2013-02-01)

“CONTRAST” STUDY: COMPARİSİON OF NEPHROPROTECTİVE THREE PROTOCOLS: ACETYLCYSTEİNESODİUM BİCARBONATE-THEOPHYLLİNE, TO PREVENT CONTRAST-İNDUCED NEPHROPATHY
by: Ilker Murat Caglar, et al.
Published: (2014-01-01)

A Drug–Drug Multicomponent Crystal of Metformin and Dobesilate: Crystal Structure Analysis and Hygroscopicity Property
by: Lan Jiang, et al.
Published: (2022-05-01)

The effect of calcium dobesilate combined with hypoglycemic drugs in the treatment of cataract NPDR and its effect on fundus microcirculation and blood ICAM-1, MCP-1 and MIF levels
by: Wang XiaoMan, et al.
Published: (2023-01-01)

Does metabolic syndrome increase contrast-induced nephropathy in patients with normal renal function?
by: Hasan Shemirani, et al.
Published: (2024-01-01)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
by: Morteza Arabmomeni, et al.
Published: (2015-01-01)

The standard dose versus double dose of N-acetylcysteine to prevent contrast-induced nephropathy; a randomized controlled clinical trial
by: Rahimeh Eskandarian, et al.
Published: (2018-07-01)

Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy
by: Özgür Günebakmaz, et al.
Published: (2013-10-01)

Pre-Procedural Assessment of the Femoral Access Route for Transcatheter Aortic Valve Implantation: Comparison of a Non-Contrast Time-of-Flight Magnetic Resonance Angiography Protocol with Contrast-Enhanced Dual-Source Computed Tomography Angiography
by: Johannes Brado, et al.
Published: (2023-10-01)

Delayed Recovery of Contrast Induced Kidney Injury Post Angiography: Rate and Risk Factors
by: Hilal B. Al-Saffar, et al.
Published: (2015-10-01)

The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials
by: Ziqiang Liu, et al.
Published: (2023-04-01)

Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis
by: Wei-Ting Chang, et al.
Published: (2023-03-01)

Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014-04-01)

Contrast-induced nephropathy: a review of literature
by: Roya Narenji Sani, et al.
Published: (2015-10-01)

Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches
by: Katiuscia Pagano, et al.
Published: (2022-09-01)

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction
by: Uğur Özkan, et al.
Published: (2023-03-01)

Prevention of contrast induced nephropathy; a cardiology point of view
by: Hashemi Mohammad, et al.
Published: (2015-01-01)

Calcium dobesilate – a perfect stranger
by: V. Yu. Bogachev, et al.
Published: (2020-06-01)

Contrast-induced nephropathy (CIN) - epidemiology, risk factors and prevention
by: Jakub Rafał Pierzchała, et al.
Published: (2022-10-01)

Albuminuria Pre-Emptively Identifies Cardiac Patients at Risk of Contrast-Induced Nephropathy
by: Laura Vicente-Vicente, et al.
Published: (2021-10-01)

Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis
by: Yan-Lin Zhou, et al.
Published: (2021-03-01)

The Incidence and Associated Risk Factors of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Emergency Setting: A Systematic Review
by: Mei-Yi Ong, et al.
Published: (2022-06-01)

Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathy
by: Deborah B. Diercks, et al.
Published: (2016-12-01)

Fully Reversible Contrast-Induced Encephalopathy Mimicking Stroke after Flow Diverter Treatment of Carotid Cave Aneurysm
by: Elie Diamandis, et al.
Published: (2023-03-01)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
by: Ina G. Panova, et al.
Published: (2023-07-01)

Non-contrast-enhanced magnetic resonance angiography as part of a kidney pretransplantation work-up in a 19-month-old boy – a case report
by: Agnieszka Postępska, et al.
Published: (2023-12-01)

CONTRAST-INDUCED NEPHROPATHY IN CARDIOLOGY PRACTICE
by: O. I. Turenko, et al.
Published: (2011-06-01)

Experimental rat models for contrast-induced nephropathy; a comprehensive review
by: Marlon Perera, et al.
Published: (2020-04-01)

Comparative study on Various Tube Voltages and Contrast Media Doses in CT Pulmonary Angiography to detect Pulmonary Thromboembolism
by: Shaymaa Khalid Abdul-Qader, et al.
Published: (2022-12-01)

Contrast-induced encephalopathy and permanent neurological deficit following cerebral angiography: A case report and review of the literature
by: Yujing Zhang, et al.
Published: (2023-01-01)